NCT00073255View on ClinicalTrials.gov

Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM)

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

December 31, 2005

Conditions
Diabetes Mellitus, Insulin-Dependent
Interventions
DRUG

hokt3g1 (ALA-ALA)

Trial Locations (1)

10032

Columbia University, New York

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00073255 - Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM) | Biotech Hunter | Biotech Hunter